Menu

Milestone Pharmaceuticals Inc. MIST

Full chart Compare
Set alert

Price alert · MIST

All alert types
0.76 USD +0.07 (+10.15%)

At closeNov 6, 2026, 6:52 PM EST

0.76 0.00 -0.37%

After hours · Nov 6, 6:52 PM ET

0.7021 Day range 0.7698
0.644 52-week range 2.95
YTD
-62.24%
1 year
-55.65%

Revenue & Expenses

Other Income → Expenses: $2.92MExpenses → Selling, General & Admin: $17.27MExpenses → Research & Development: $18.11MExpenses → Other Operating Expenses: $28.30MExpenses → Interest Expense: $3.84MGross Profit → Expenses: $1.55MRevenue → Gross Profit: $1.55MNet Loss → Expenses: $63.06MOther Income$2.92MGross Profit$1.55MNet Loss$63.06MExpenses$67.52MSelling, General & Admin$17.27MResearch & Development$18.11MOther Operating Expenses$28.30MInterest Expense$3.84MRevenue$1.55M

Latest period ending Dec 31, 2025 · select a line to chart its full history

MIST annual income statement
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
1.55M01.00M5.00M15.00M
1.55M01.00M5.00M15.00M
-62.14M-42.10M-61.10M-59.64M-43.07M
-63.06M-41.52M-59.69M-58.39M-42.85M
-0.75-0.67-1.39-1.38-1.02
MIST annual balance sheet
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
73.05M25.31M13.76M7.64M114.14M
113.56M75.50M75.23M74.48M119.85M
71.79M62.35M58.45M8.13M7.25M
58.38M54.80M51.77M2.49M698.00K
41.77M13.15M16.77M66.35M112.60M
MIST annual cash flow
Fiscal yearFY 2025 Dec 31, 2025FY 2024 Dec 31, 2024FY 2023 Dec 31, 2023FY 2022 Dec 31, 2022FY 2021 Dec 31, 2021
-49.04M-28.85M-46.42M-52.47M-33.22M
11.25M8.28M4.76M-57.12M70.00M
85.53M32.12M47.79M3.09M5.05M
-302.00K-33.00K-112.00K-272.00K0
47.73M11.55M6.12M-106.50M41.83M